BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 11110839)

  • 1. The deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells.
    Bhura-Bandali FN; Suh M; Man SF; Clandinin MT
    J Nutr; 2000 Dec; 130(12):2870-5. PubMed ID: 11110839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis.
    Werner A; Bongers ME; Bijvelds MJ; de Jonge HR; Verkade HJ
    J Lipid Res; 2004 Dec; 45(12):2277-86. PubMed ID: 15466369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease.
    Persu A; Devuyst O; Lannoy N; Materne R; Brosnahan G; Gabow PA; Pirson Y; Verellen-Dumoulin C
    J Am Soc Nephrol; 2000 Dec; 11(12):2285-2296. PubMed ID: 11095651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
    Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM
    J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil (Viagra) corrects DeltaF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis.
    Dormer RL; Harris CM; Clark Z; Pereira MM; Doull IJ; Norez C; Becq F; McPherson MA
    Thorax; 2005 Jan; 60(1):55-9. PubMed ID: 15618584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tgf-β1 inhibits Cftr biogenesis and prevents functional rescue of ΔF508-Cftr in primary differentiated human bronchial epithelial cells.
    Snodgrass SM; Cihil KM; Cornuet PK; Myerburg MM; Swiatecka-Urban A
    PLoS One; 2013; 8(5):e63167. PubMed ID: 23671668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis transmembrane conductance regulator (CFTR) activity in nasal epithelial cells from cystic fibrosis patients with severe genotypes.
    Andersson C; Dragomir A; Hjelte L; Roomans GM
    Clin Sci (Lond); 2002 Oct; 103(4):417-24. PubMed ID: 12241542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERp29 regulates DeltaF508 and wild-type cystic fibrosis transmembrane conductance regulator (CFTR) trafficking to the plasma membrane in cystic fibrosis (CF) and non-CF epithelial cells.
    Suaud L; Miller K; Alvey L; Yan W; Robay A; Kebler C; Kreindler JL; Guttentag S; Hubbard MJ; Rubenstein RC
    J Biol Chem; 2011 Jun; 286(24):21239-53. PubMed ID: 21525008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purinergic signaling underlies CFTR control of human airway epithelial cell volume.
    Braunstein GM; Zsembery A; Tucker TA; Schwiebert EM
    J Cyst Fibros; 2004 Jun; 3(2):99-117. PubMed ID: 15463893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of deltaF508 CFTR in a cystic fibrosis respiratory epithelial cell line by 4-phenylbutyrate, genistein and CPX.
    Andersson C; Roomans GM
    Eur Respir J; 2000 May; 15(5):937-41. PubMed ID: 10853862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular species compositions of lung and pancreas phospholipids in the cftr(tm1HGU/tm1HGU) cystic fibrosis mouse.
    Dombrowsky H; Clark GT; Rau GA; Bernhard W; Postle AD
    Pediatr Res; 2003 Mar; 53(3):447-54. PubMed ID: 12595593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
    Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
    Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells.
    Simsek S; Zhou T; Robinson CL; Tsai SY; Crespo M; Amin S; Lin X; Hon J; Evans T; Chen S
    Stem Cells Transl Med; 2016 May; 5(5):572-9. PubMed ID: 27034411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis.
    Kälin N; Claass A; Sommer M; Puchelle E; Tümmler B
    J Clin Invest; 1999 May; 103(10):1379-89. PubMed ID: 10330420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence for direct activation of the cystic fibrosis transmembrane conductance regulator by 8-cyclopentyl-1,3-dipropylxanthine.
    Kunzelmann K; Briel M; Schreiber R; Ricken S; Nitschke R; Greger R
    Cell Physiol Biochem; 1998; 8(4):185-93. PubMed ID: 9694345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis.
    Antigny F; Norez C; Dannhoffer L; Bertrand J; Raveau D; Corbi P; Jayle C; Becq F; Vandebrouck C
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):83-90. PubMed ID: 20203293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annexin A5 increases the cell surface expression and the chloride channel function of the DeltaF508-cystic fibrosis transmembrane regulator.
    Le Drévo MA; Benz N; Kerbiriou M; Giroux-Metges MA; Pennec JP; Trouvé P; Férec C
    Biochim Biophys Acta; 2008 Oct; 1782(10):605-14. PubMed ID: 18773956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ΔF508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Is Associated With Progressive Insulin Resistance and Decreased Functional β-Cell Mass in Mice.
    Fontés G; Ghislain J; Benterki I; Zarrouki B; Trudel D; Berthiaume Y; Poitout V
    Diabetes; 2015 Dec; 64(12):4112-22. PubMed ID: 26283735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-nitrosoglutathione increases cystic fibrosis transmembrane regulator maturation.
    Zaman K; McPherson M; Vaughan J; Hunt J; Mendes F; Gaston B; Palmer LA
    Biochem Biophys Res Commun; 2001 Jun; 284(1):65-70. PubMed ID: 11374871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.